CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing a 3D in vitro model to study drug teratogenicity during early human development. By automating this model, it aims to improve the understanding of how medications affect pregnancy, ultimately ensuring safer drug use for expectant mothers.
Drug teratogenicity, namely the potential of a drug to cause birth defects, is a major concern for anyone becoming pregnant.
The infamous Thalidomide case in the 1960s raised public awareness of this issue.
Notably, only about 30% of embryos successfully implant during early development, but the reasons for this low rate remain unclear.
Nobody knows if this is due to the teratogenic effects of common drugs, or a lack of essential nutrients needed for development, similar to how folate is used to…
UNIVERSITA DEGLI STUDI DI PADOVA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Italy, ROMA RM
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
